These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29338702)

  • 21. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.
    Hui C; Dunn J; Morton R; Staub LP; Tran A; Hargreaves S; Greenaway C; Biggs BA; Christensen R; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30241320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening.
    Kärki T; Napoli C; Riccardo F; Fabiani M; Dente MG; Carballo M; Noori T; Declich S
    Int J Environ Res Public Health; 2014 Oct; 11(10):11004-14. PubMed ID: 25337945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review.
    Pottie K; Lotfi T; Kilzar L; Howeiss P; Rizk N; Akl EA; Dias S; Biggs BA; Christensen R; Rahman P; Magwood O; Tran A; Rowbotham N; Pharris A; Noori T; Pareek M; Morton R
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.
    Suijkerbuijk AWM; van Hoek AJ; Koopsen J; de Man RA; Mangen MJ; de Melker HE; Polder JJ; de Wit GA; Veldhuijzen IK
    PLoS One; 2018; 13(11):e0207037. PubMed ID: 30408079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian migrants study: An HCV and HBV micro-elimination pilot project.
    Colucci G; Uceda Renteria S; Lunghi G; Ceriotti F; Sguazzini E; Spalenza S; Regazzo C; Lampertico P; Colombo M
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101852. PubMed ID: 34923181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
    Carrillo-Santisteve P; Tavoschi L; Severi E; Bonfigli S; Edelstein M; Byström E; Lopalco P;
    Lancet Infect Dis; 2017 Oct; 17(10):e306-e319. PubMed ID: 28645862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.
    Nellums LB; Thompson H; Holmes A; Castro-Sánchez E; Otter JA; Norredam M; Friedland JS; Hargreaves S
    Lancet Infect Dis; 2018 Jul; 18(7):796-811. PubMed ID: 29779917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register.
    Tiittala P; Ristola M; Liitsola K; Ollgren J; Koponen P; Surcel HM; Hiltunen-Back E; Davidkin I; Kivelä P
    BMC Infect Dis; 2018 Mar; 18(1):137. PubMed ID: 29558910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?
    Noori T; Hargreaves S; Greenaway C; van der Werf M; Driedger M; Morton RL; Hui C; Requena-Mendez A; Agbata E; Myran DT; Pareek M; Campos-Matos I; Nielsen RT; Semenza J; Nellums LB; Pottie K;
    Travel Med Infect Dis; 2021; 39():101715. PubMed ID: 32389827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area.
    Tavoschi L; Mason L; Petriti U; Bunge E; Veldhuijzen I; Duffell E
    J Hosp Infect; 2019 Aug; 102(4):359-368. PubMed ID: 30885816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.
    Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E
    BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.
    Requena-Méndez A; Aldasoro E; de Lazzari E; Sicuri E; Brown M; Moore DA; Gascon J; Muñoz J
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003540. PubMed ID: 25680190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in Europe: does migrant integration have mental health payoffs? A cross-national comparison of 20 European countries.
    Levecque K; Van Rossem R
    Ethn Health; 2015; 20(1):49-65. PubMed ID: 24517205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.